Blair William & Co. IL lifted its holdings in Aflac Incorporated (NYSE:AFL – Free Report) by 2.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 18,921 shares of the financial services provider’s stock after acquiring an additional 373 shares during the period. Blair William & Co. IL’s holdings in Aflac were worth $1,957,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors also recently made changes to their positions in AFL. Vanguard Group Inc. lifted its stake in Aflac by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 51,340,298 shares of the financial services provider’s stock valued at $5,310,640,000 after buying an additional 653,275 shares during the period. Charles Schwab Investment Management Inc. lifted its position in shares of Aflac by 1.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,226,681 shares of the financial services provider’s stock valued at $333,768,000 after acquiring an additional 47,119 shares during the period. Amundi boosted its stake in Aflac by 81.1% during the fourth quarter. Amundi now owns 2,753,513 shares of the financial services provider’s stock worth $285,181,000 after acquiring an additional 1,232,683 shares in the last quarter. Guinness Asset Management LTD increased its stake in Aflac by 5.2% in the fourth quarter. Guinness Asset Management LTD now owns 2,395,045 shares of the financial services provider’s stock valued at $247,682,000 after purchasing an additional 118,720 shares in the last quarter. Finally, Assetmark Inc. increased its stake in Aflac by 2.0% in the fourth quarter. Assetmark Inc. now owns 1,616,772 shares of the financial services provider’s stock valued at $167,239,000 after purchasing an additional 32,220 shares in the last quarter. 67.44% of the stock is owned by institutional investors and hedge funds.
Insider Activity
In other news, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $107.63, for a total transaction of $107,630.00. Following the sale, the director now owns 25,393 shares in the company, valued at $2,733,048.59. This represents a 3.79 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Charles D. Lake II sold 29,802 shares of the business’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the completion of the transaction, the director now owns 49,962 shares of the company’s stock, valued at approximately $5,360,422.98. The trade was a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.
Wall Street Analysts Forecast Growth
Get Our Latest Analysis on Aflac
Aflac Trading Up 1.1 %
Shares of NYSE AFL opened at $112.44 on Wednesday. Aflac Incorporated has a 1 year low of $79.31 and a 1 year high of $115.50. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. The firm has a 50-day moving average of $106.71 and a 200 day moving average of $107.71. The stock has a market cap of $61.37 billion, a P/E ratio of 11.71, a price-to-earnings-growth ratio of 3.24 and a beta of 0.93.
Aflac (NYSE:AFL – Get Free Report) last released its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, sell-side analysts expect that Aflac Incorporated will post 6.88 EPS for the current fiscal year.
Aflac Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Stories
- Five stocks we like better than Aflac
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Buffett Trims Equities, But Still Keeps Buying This Stock
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.